Microvast reported a significant increase in revenue, exceeding expectations with a 145.5% increase compared to Q1 2021. The company is focused on sales growth, expanding its order book, and executing capacity expansion plans.
Revenue increased by 145.5% to $36.7 million compared to Q1 2021.
Gross profit improved to $13.0 thousand, compared to a gross loss of $1.2 million in Q1 2021.
The backlog at the end of Q1 2022 was $120.8 million, an increase of 85.6% compared to $65.1 million at the end of Q1 2021.
Capital expenditures during Q1 2022 were $41.1 million compared to $25.4 million in Q1 2021.
Microvast continues to expect revenue for the year ending December 31, 2022 to grow 35% to 45% compared to the year ended December 31, 2021; however, achievement of the Company’s revenue guidance could be impacted if the macro backdrop of increasing inflation, supply chain disruptions, conflict in Ukraine and COVID restrictions in China deteriorates further.